FIRALIS S.A.

Accell Clinical Research is an international full-service Contract Research Organization (CRO) managing Phase I-III clinical trials for 10+ years across Eastern Europe. With local presence, including highly qualified medical staff and legal entities in the region, we successfully recruit patients both in EU and outside EU in post-Soviet countries (CIS). All together we provide guaranteed fast patient recruitment in 20+ countries across the region.

⬇︎ ACCELL'S SERVICES for Phase I-III clinical trials:

• Strategic guidance and trial set-up:
• Feasibility research and site selection
• Study documentation development
• Regulatory support
• Clinical supply import and management
• Selection and management of clinical study vendors
• Project management
• Clinical & medical monitoring
• Data management and biostatistics
• Quality assurance
• Safety management
• TMF/eTMF services
• Functional outsourcing of a clinical team

⬇︎ THERAPEUTIC AREAS
• Oncology
• Cardiovascular
• Immunology
• Gastroenterology
• Neurology
• Endocrinology

Covalab is a French biotechnology company specialized in antibody engineering, founded in 1995.

We are expert in the design and development of antibody (polyclonal, monoclonal scFv, FAb, VHH, recombinant antibodies) using antigen or DNA immunization. In addition, we offer purified and labeling antibodies, peptide synthesis for research use, diagnostic and therapeuthic. As a producer, we supply many distributors to sale our innovative and high quality antibodies. Wide range of those products are available in our website.

The service activity of CovalAb represents the top of the scientific and technical iceberg which the team at CovalAb has put together. Indeed, the scientists at CovalAb have more than 30 years of experience in the chemical modification of antigens and antibodies destined for diagnosis and therapy.

A list, by no means complete of some of their achievements:
- In biomedicine, includes the production of: antibodies directed against new tumour markers, antibodies as gene vectors in cancerology, antibodies reacting specifically with cerebral protein aggregates in neurology, diagnostic kits for detecting patients with autoimmune disease such as rheumatoid arthritis and celiac disease.
- In agro-food, the development of complete diagnostic kits including the antibodies and the chemically modified immunogens for the detection of mycotoxins, phycotoxins, pesticides and polyaromatic hydrocarbons.

Our mission is to give to researchers every day high quality antibodies and powerful tools to accelerate your research and move on to discovery. We help our clients to face new challenges in biology and to improve life thanks to translational research, personalized medicine, stem cell therapy and food safety.

NEUROFIT, founded in 1996, is a pre-clinical CRO (Contract Research Organization) based in France and offering a comprehensive list of disease models and screening assays in the fields of psychiatry, neurology, multiple sclerosis, diabetes and pain. Neurofit works for major pharmaceutical and Biotech companies in Europe and the USA.
Neurofit’s core expertise in CNS and PNS includes animal behavior techniques, nerve conduction velocity measure, nerve fiber morphometry, primary neuronal cell cultures. Neurofit has long-standing experiences in psychiatric, neurodegenerative and autoimmune / inflammatory disorders. Our disease models are clinically relevant and predictive.
Neurofit routinely performs, as part of a study, collection of blood, serum plasma, cerebrospinal fluid as well as dissection of brain microstructures from compound-treated animals to provide customers with useful samples for their pharmacokinetic, biochemistry and immunochemistry analyses.

EastHORN is a full service CRO with operations in key locations in Western Europe and offices covering the entire European region. Experienced in Phase I to Phase IV studies across all therapeutic areas including Neurology & Psychiatry, Oncology, Cardiovascular Diseases, Infectious & Parasitic Diseases and Gastrointestinal Diseases. The large and diverse patient populations also make this region an ideal location for rare disease studies.

EastHORN has over 120 employees and a presence in virtually every European country, Established in 2004 and boasting a highly experienced management team EastHORN provides a high quality service combined with the rapid recruitment for which this region is renowned.

EastHORN’s response to the coronavirus Covid-19 crisis

Our priorities at this challenging time are the well-being of our staff and their families, and of the clinical staff and patients in our clinical trials. We are monitoring the Covid-19 pandemic situation in each of the countries in which we operate and complying with local/national directives. The vast majority of our staff are able to work from their homes and, where possible, travel has been stopped.
We are making every effort to minimize the impact on our business and our clients’ projects and our project managers are keeping their clients updated on the challenges and solutions in their respective projects. In many cases monitoring visits to clinical facilities have been suspended for the time being; these have been replaced by remote monitoring and critical data review, with non-essential activities being postponed. We want to assure our clients that we have robust business continuity plans in place, that we are adequately staffed and that we remain focused on their projects. As soon as we can be up and running normally again we will we will be doing our best to recover from this challenge.

Qualitis Ltd, is a Full-Service Clinical Research and Medical Consulting Organization based in Greece and offering a comprehensive portfolio of clinical development and medical consulting services to the Pharmaceutical, Biotechnology and Medical Device industries.

Through a commitment to a Company culture of superior quality service, integrity and innovation, Qualitis focuses on exceeding its customers particular needs and expectations.

Qualitis Team possesses an in-depth and long-term experience and expertise in both clinical research and medical-marketing environment and is strongly dedicated in constant learning and continuous improvement driven to create added value for our customers and become an integral part of their business success.

With a strong focus on people and standards, Qualitis has built upon the 3 milestones of business success: Quality, Commitment and Customer Trust.

Our specialty areas include but are not limited to the following:
-Cardiovascular diseases
-Neurology & Psychiatry
-Pulmonary/Respiratory
-Genitourinary
-Gastroenterology
-Oncology
-Orthopedics
-Pediatrics
-Biotechnology
-Allergy/Immunology
-Dermatology
-Virology
-Endocrinology
-Hematology
-Ophthalmology

Areas of Operation-Projects Portfolio:
-Phase II-IV Clinical Trials
-Medical Device Studies
-Non-Interventional Studies
-Pharmacovigilance Studies
-IIS (Investigator Initiated Studies)
-Epidemiological Studies
-Market Surveys

Customers Profile:
-Pharmaceutical Companies
-Biotechnology Companies
-Medical Devices Companies
-Academic Research Institutes & Hospitals
-International CROs

Contact Details: E-mail: info@qualitis.gr
Telephone: +30 210-7797750
Fax: +30 210-7470441